Indications for stress echocardiography can be grouped into very broad categories, which eventually could encompass the overwhelming majority of patients: diagnosis of coronary artery disease; prognosis and risk stratification in patients with established diagnosis, for instance, after myocardial infarction; assessment of preoperative risk; evaluation for cardiac etiology of exertional dyspnea; evaluation after revascularization; localization of ischemia. As a rule, the less informative the exercise ECG test is, the stricter the indication for stress echocardiography is. Out of five patients, one is unable to exercise, one exercises submaximally, and one exercises maximally but the ECG is uninterpretable. The three main specific indications for pharmacological stress echocardiography can be summarized as follows: (1) patients in whom the exercise stress test is contraindicated (e.g., patients with severe arterial hypertension); (2) patients in whom the exercise stress test is not feasible (e.g., those with intermittent claudication); (3) patients in whom the exercise stress test was nondiagnostic or gave ambiguous results: inability to achieve the target heart rate response; presence of chest pain in the absence of significant electrocardiographic changes; a concomitance of conditions lowering the reliability of the ECG marker of ischemia (female sex, arterial hypertension, repolarization abnormalities on ECG under resting conditions or after hyperventilation, and need to continue drugs such as digitalis or antiarrhythmics that potentially induce ST-T changes).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Philbrick JT, Horwitz RI, Feinstein AR (1980) Methodologic problems of exercise testing for coronary artery disease: groups, analysis and bias. Am J Cardiol 46:807–812
Lu C, Picano E, Pingitore A,et al (1995) Complex coronary artery lesion morphology influences results of stress echocardiography. Circulation 91:1669–1675
Heyman J, Salvade P, Picano E,et al (1997) The elusive link between coronary lesion morphology and dobutamine stress echocardiography results. The EDIC (Echo Dobutamine International Cooperative) Study Group. Int J Card Imaging 13:395–401
Gliozheni E, Picano E, Bernardino L, et al (1996) Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing. Am J Cardiol 78:1419–1424
Beleslin BD, Ostojic M, Djordjevic-Dikic A, et al (1999) Integrated evaluation of relation between coronary lesion features and stress echocardiography results: the importance of coronary lesion morphology. J Am Coll Cardiol 33:717–726
Marwick T, Willemart B, D'Hondt AM, et al (1993) Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 87:345–354
Severi S, Picano E, Michelassi C, et al (1994) Diagnostic and prognostic value of dipyrida-mole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography. Circulation 89:1160–1173
Marwick T, D'Hondt AM, Baudhuin T, et al (1993) Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 22:159–167
Parodi G, Picano E, Marcassa C, et al (1999) High dose dipyridamole stress imaging: simultaneous sestamibi scintigraphy and two-dimensional echocardiography for the detection and evaluation of coronary artery disease. Coron Artery Dis 10:177–184
Quinones MA, Verani MS, Haichin RM, et al (1992) Exercise echocardiography versus 201Tl single-photon emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients. Circulation 85:1026–1031
De Albuquerque Fonseca L, Picano E (2001) Comparison of dipyridamole and exercise stress echocardiography for detection of coronary artery disease (a meta-analysis). Am J Cardiol 87:1193–1196
Picano E, Molinaro S, Pasanisi E (2008) The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis. Cardiovasc Ultrasound 6:30
Imran MB, Palinkas A, Picano E (2002) Head to head comparison of dipyridamole echocar-diography and stress perfusion scintigraphy for the detection of coronary artery disease: a metaanalysis. Int J Cardiovasc Imaging 19:23–28
Pingitore A, Picano E, Colosso MQ, et al (1996) The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 27:1164–1170
Pingitore A, Picano E, Varga A, et al (1999) Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 34:1769–1777
Picano E, Ostojic M, Varga A, et al (1996) Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability. J Am Coll Cardiol 27:1422–1428
Martin T W, Seaworth J F, Johns J P, et al (1992) Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med 116:190–196
Beleslin BD, Ostojic M, Stepanovic J, et al (1994) Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 90:1168–1176
Sochowski RA,Yvorchuk KJ,Yang Y, et al (1995) Dobutamine and dipyridamole stress echocardiography in patients with a low incidence of severe coronary artery disease. J Am Soc Echocardiogr 8:482–487
Pellikka PA, McCully RB (2007) Stress echocardiography: so much to do, so little time. J Am Coll Cardiol 50:1990–1991
Sicari R, Nihoyannopoulos P, Evangelista A, et al; European Association of Echocardiography (2008) Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 9:415–437
Douglas PS, Khandheria B, Stainback R F, et al; American College of Cardiology Foundation; American Society of Echocardiography; American College of Emergency Physicians; American Heart Association; American Society of Nuclear Cardiology; Society for Cardiovascular Angiography and Interventions; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance (2008) ACCF/ASE/ACEP/AHA/ASNC/ SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiog-raphy and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. J Am Coll Cardiol 51:1127–1147
Ferrara N, Coltorti F, Leosco D, et al (1995) Protective effect of beta-blockade on dipyrida-mole-induced myocardial ischaemia. Role of heart rate. Eur Heart J 16:903–908
Ferrara N, Longobardi G, Nicolino A, et al (1992) Effect of beta-adrenoceptor blockade on dipy-ridamole-induced myocardial asynergies in coronary artery disease. Am J Cardiol 70:724–727
Longobardi G, Ferrara N, Leosco D, et al (1995) Failure of protective effect of captopril and enalapril on exercise and dipyridamole-induced myocardial ischemia. Am J Cardiol 76:255–258
Fioretti PM, Poldermans D, Salustri A, et al (1994) Atropine increases the accuracy of dob-utamine stress echocardiography in patients taking beta-blockers. Eur Heart J 15:355–360
Dodi C, Pingitore A, Sicari R, et al (1997) Effects of antianginal therapy with a calcium antagonist and nitrates on dobutamine-atropine stress echocardiography. Comparison with exercise electrocardiography. Eur Heart J 18:242–247
Gibbons RJ, Balady GJ, Timothy Bricker J, et al (2002) ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 40:1531–1540
Fox K, Garcia MA, Ardissino D, et al; Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG) (2006) Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27:1341–1381
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Picano, E. (2009). Diagnostic Results and Indications. In: Picano, E. (eds) Stress Echocardiography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76466-3_19
Download citation
DOI: https://doi.org/10.1007/978-3-540-76466-3_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-76465-6
Online ISBN: 978-3-540-76466-3
eBook Packages: MedicineMedicine (R0)